1 Market Overview

1.1 Product Overview and Scope of Recombinant Protein Drug R&D

1.2 Classification of Recombinant Protein Drug R&D by Type

1.2.1 Overview: Global Recombinant Protein Drug R&D Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Recombinant Protein Drug R&D Revenue Market Share by Type in 2020

1.2.3 Peptide Hormones

1.2.4 Hematopoietic Factor

1.2.5 Cytokines

1.2.6 Plasma Protein Factor

1.2.7 Recombinase

1.2.8 Fusion Protein

1.2.9 Other

1.3 Global Recombinant Protein Drug R&D Market by Application

1.3.1 Overview: Global Recombinant Protein Drug R&D Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diabetes

1.3.3 Dwarfism

1.3.4 Hemophilia

1.3.5 Heart Disease

1.3.6 Cancer

1.3.7 Other

1.4 Global Recombinant Protein Drug R&D Market Size & Forecast

1.5 Global Recombinant Protein Drug R&D Market Size and Forecast by Region

1.5.1 Global Recombinant Protein Drug R&D Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Recombinant Protein Drug R&D Market Size by Region, (2016-2021)

1.5.3 North America Recombinant Protein Drug R&D Market Size and Prospect (2016-2026)

1.5.4 Europe Recombinant Protein Drug R&D Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Recombinant Protein Drug R&D Market Size and Prospect (2016-2026)

1.5.6 South America Recombinant Protein Drug R&D Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Recombinant Protein Drug R&D Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Recombinant Protein Drug R&D Market Drivers

1.6.2 Recombinant Protein Drug R&D Market Restraints

1.6.3 Recombinant Protein Drug R&D Trends Analysis

2 Company Profiles

2.1 Eli Lilly

2.1.1 Eli Lilly Details

2.1.2 Eli Lilly Major Business

2.1.3 Eli Lilly Recombinant Protein Drug R&D Product and Solutions

2.1.4 Eli Lilly Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Eli Lilly Recent Developments and Future Plans

2.2 Novo Nordisk

2.2.1 Novo Nordisk Details

2.2.2 Novo Nordisk Major Business

2.2.3 Novo Nordisk Recombinant Protein Drug R&D Product and Solutions

2.2.4 Novo Nordisk Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novo Nordisk Recent Developments and Future Plans

2.3 Amgen

2.3.1 Amgen Details

2.3.2 Amgen Major Business

2.3.3 Amgen Recombinant Protein Drug R&D Product and Solutions

2.3.4 Amgen Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Amgen Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Recombinant Protein Drug R&D Product and Solutions

2.4.4 Merck Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi Recombinant Protein Drug R&D Product and Solutions

2.5.4 Sanofi Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Recombinant Protein Drug R&D Product and Solutions

2.6.4 Pfizer Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Roche

2.7.1 Roche Details

2.7.2 Roche Major Business

2.7.3 Roche Recombinant Protein Drug R&D Product and Solutions

2.7.4 Roche Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Roche Recent Developments and Future Plans

2.8 Gensci

2.8.1 Gensci Details

2.8.2 Gensci Major Business

2.8.3 Gensci Recombinant Protein Drug R&D Product and Solutions

2.8.4 Gensci Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Gensci Recent Developments and Future Plans

2.9 Ankebio

2.9.1 Ankebio Details

2.9.2 Ankebio Major Business

2.9.3 Ankebio Recombinant Protein Drug R&D Product and Solutions

2.9.4 Ankebio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Ankebio Recent Developments and Future Plans

2.10 United Cell

2.10.1 United Cell Details

2.10.2 United Cell Major Business

2.10.3 United Cell Recombinant Protein Drug R&D Product and Solutions

2.10.4 United Cell Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 United Cell Recent Developments and Future Plans

2.11 Sinobioway Hygene

2.11.1 Sinobioway Hygene Details

2.11.2 Sinobioway Hygene Major Business

2.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Product and Solutions

2.11.4 Sinobioway Hygene Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Sinobioway Hygene Recent Developments and Future Plans

2.12 Kexing

2.12.1 Kexing Details

2.12.2 Kexing Major Business

2.12.3 Kexing Recombinant Protein Drug R&D Product and Solutions

2.12.4 Kexing Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Kexing Recent Developments and Future Plans

2.13 Dongbao

2.13.1 Dongbao Details

2.13.2 Dongbao Major Business

2.13.3 Dongbao Recombinant Protein Drug R&D Product and Solutions

2.13.4 Dongbao Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Dongbao Recent Developments and Future Plans

2.14 3sbio

2.14.1 3sbio Details

2.14.2 3sbio Major Business

2.14.3 3sbio Recombinant Protein Drug R&D Product and Solutions

2.14.4 3sbio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 3sbio Recent Developments and Future Plans

2.15 Gan&Lee

2.15.1 Gan&Lee Details

2.15.2 Gan&Lee Major Business

2.15.3 Gan&Lee Recombinant Protein Drug R&D Product and Solutions

2.15.4 Gan&Lee Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Gan&Lee Recent Developments and Future Plans

2.16 Hengrui

2.16.1 Hengrui Details

2.16.2 Hengrui Major Business

2.16.3 Hengrui Recombinant Protein Drug R&D Product and Solutions

2.16.4 Hengrui Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Hengrui Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Recombinant Protein Drug R&D Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Recombinant Protein Drug R&D Players Market Share

3.2.2 Top 10 Recombinant Protein Drug R&D Players Market Share

3.2.3 Market Competition Trend

3.3 Recombinant Protein Drug R&D Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Recombinant Protein Drug R&D Revenue and Market Share by Type (2016-2021)

4.2 Global Recombinant Protein Drug R&D Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Recombinant Protein Drug R&D Revenue Market Share by Application (2016-2021)

5.2 Recombinant Protein Drug R&D Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Recombinant Protein Drug R&D Revenue by Type (2016-2026)

6.2 North America Recombinant Protein Drug R&D Revenue by Application (2016-2026)

6.3 North America Recombinant Protein Drug R&D Market Size by Country

6.3.1 North America Recombinant Protein Drug R&D Revenue by Country (2016-2026)

6.3.2 United States Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

6.3.3 Canada Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

6.3.4 Mexico Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Recombinant Protein Drug R&D Revenue by Type (2016-2026)

7.2 Europe Recombinant Protein Drug R&D Revenue by Application (2016-2026)

7.3 Europe Recombinant Protein Drug R&D Market Size by Country

7.3.1 Europe Recombinant Protein Drug R&D Revenue by Country (2016-2026)

7.3.2 Germany Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

7.3.3 France Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

7.3.5 Russia Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

7.3.6 Italy Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2016-2026)

8.2 Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2016-2026)

8.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region

8.3.1 Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2016-2026)

8.3.2 China Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

8.3.3 Japan Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

8.3.4 South Korea Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

8.3.5 India Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

8.3.7 Australia Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Recombinant Protein Drug R&D Revenue by Type (2016-2026)

9.2 South America Recombinant Protein Drug R&D Revenue by Application (2016-2026)

9.3 South America Recombinant Protein Drug R&D Market Size by Country

9.3.1 South America Recombinant Protein Drug R&D Revenue by Country (2016-2026)

9.3.2 Brazil Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

9.3.3 Argentina Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2016-2026)

10.2 Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2016-2026)

10.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country

10.3.1 Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2016-2026)

10.3.2 Turkey Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

10.3.4 UAE Recombinant Protein Drug R&D Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Recombinant Protein Drug R&D Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Recombinant Protein Drug R&D Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Recombinant Protein Drug R&D Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Recombinant Protein Drug R&D Revenue (USD Million) by Region (2016-2021)

Table 5. Global Recombinant Protein Drug R&D Revenue Market Share by Region (2021-2026)

Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 7. Eli Lilly Major Business

Table 8. Eli Lilly Recombinant Protein Drug R&D Product and Solutions

Table 9. Eli Lilly Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 11. Novo Nordisk Major Business

Table 12. Novo Nordisk Recombinant Protein Drug R&D Product and Solutions

Table 13. Novo Nordisk Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Amgen Corporate Information, Head Office, and Major Competitors

Table 15. Amgen Major Business

Table 16. Amgen Recombinant Protein Drug R&D Product and Solutions

Table 17. Amgen Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Recombinant Protein Drug R&D Product and Solutions

Table 21. Merck Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Recombinant Protein Drug R&D Product and Solutions

Table 25. Sanofi Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Recombinant Protein Drug R&D Product and Solutions

Table 29. Pfizer Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Roche Corporate Information, Head Office, and Major Competitors

Table 31. Roche Major Business

Table 32. Roche Recombinant Protein Drug R&D Product and Solutions

Table 33. Roche Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Gensci Corporate Information, Head Office, and Major Competitors

Table 35. Gensci Major Business

Table 36. Gensci Recombinant Protein Drug R&D Product and Solutions

Table 37. Gensci Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Ankebio Corporate Information, Head Office, and Major Competitors

Table 39. Ankebio Major Business

Table 40. Ankebio Recombinant Protein Drug R&D Product and Solutions

Table 41. Ankebio Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. United Cell Corporate Information, Head Office, and Major Competitors

Table 43. United Cell Major Business

Table 44. United Cell Recombinant Protein Drug R&D Product and Solutions

Table 45. United Cell Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Sinobioway Hygene Corporate Information, Head Office, and Major Competitors

Table 47. Sinobioway Hygene Major Business

Table 48. Sinobioway Hygene Recombinant Protein Drug R&D Product and Solutions

Table 49. Sinobioway Hygene Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Kexing Corporate Information, Head Office, and Major Competitors

Table 51. Kexing Major Business

Table 52. Kexing Recombinant Protein Drug R&D Product and Solutions

Table 53. Kexing Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Dongbao Corporate Information, Head Office, and Major Competitors

Table 55. Dongbao Major Business

Table 56. Dongbao Recombinant Protein Drug R&D Product and Solutions

Table 57. Dongbao Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. 3sbio Corporate Information, Head Office, and Major Competitors

Table 59. 3sbio Major Business

Table 60. 3sbio Recombinant Protein Drug R&D Product and Solutions

Table 61. 3sbio Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Gan&Lee Corporate Information, Head Office, and Major Competitors

Table 63. Gan&Lee Major Business

Table 64. Gan&Lee Recombinant Protein Drug R&D Product and Solutions

Table 65. Gan&Lee Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Hengrui Corporate Information, Head Office, and Major Competitors

Table 67. Hengrui Major Business

Table 68. Hengrui Recombinant Protein Drug R&D Product and Solutions

Table 69. Hengrui Recombinant Protein Drug R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Global Recombinant Protein Drug R&D Revenue (USD Million) by Players (2019-2021)

Table 71. Global Recombinant Protein Drug R&D Revenue Share by Players (2019-2021)

Table 72. Breakdown of Recombinant Protein Drug R&D by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Recombinant Protein Drug R&D Players Head Office, Products and Services Provided

Table 74. Recombinant Protein Drug R&D Mergers & Acquisitions in the Past Five Years

Table 75. Recombinant Protein Drug R&D New Entrants and Expansion Plans

Table 76. Global Recombinant Protein Drug R&D Revenue (USD Million) by Type (2016-2021)

Table 77. Global Recombinant Protein Drug R&D Revenue Share by Type (2016-2021)

Table 78. Global Recombinant Protein Drug R&D Revenue Forecast by Type (2021-2026)

Table 79. Global Recombinant Protein Drug R&D Revenue by Application (2016-2021)

Table 80. Global Recombinant Protein Drug R&D Revenue Forecast by Application (2021-2026)

Table 81. North America Recombinant Protein Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 82. North America Recombinant Protein Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 83. North America Recombinant Protein Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 84. North America Recombinant Protein Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 85. North America Recombinant Protein Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 86. North America Recombinant Protein Drug R&D Revenue by Country (2021-2026) & (USD Million)

Table 87. Europe Recombinant Protein Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 88. Europe Recombinant Protein Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 89. Europe Recombinant Protein Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 90. Europe Recombinant Protein Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 91. Europe Recombinant Protein Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 92. Europe Recombinant Protein Drug R&D Revenue by Country (2021-2026) & (USD Million)

Table 93. Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 94. Asia-Pacific Recombinant Protein Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 95. Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 96. Asia-Pacific Recombinant Protein Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 97. Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2016-2021) & (USD Million)

Table 98. Asia-Pacific Recombinant Protein Drug R&D Revenue by Region (2021-2026) & (USD Million)

Table 99. South America Recombinant Protein Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 100. South America Recombinant Protein Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 101. South America Recombinant Protein Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 102. South America Recombinant Protein Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 103. South America Recombinant Protein Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 104. South America Recombinant Protein Drug R&D Revenue by Country (2021-2026) & (USD Million)

Table 105. Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2016-2021) & (USD Million)

Table 106. Middle East & Africa Recombinant Protein Drug R&D Revenue by Type (2021-2026) & (USD Million)

Table 107. Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2016-2021) & (USD Million)

Table 108. Middle East & Africa Recombinant Protein Drug R&D Revenue by Application (2021-2026) & (USD Million)

Table 109. Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2016-2021) & (USD Million)

Table 110. Middle East & Africa Recombinant Protein Drug R&D Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Recombinant Protein Drug R&D Picture

Figure 2. Global Recombinant Protein Drug R&D Revenue Market Share by Type in 2020

Figure 3. Peptide Hormones

Figure 4. Hematopoietic Factor

Figure 5. Cytokines

Figure 6. Plasma Protein Factor

Figure 7. Recombinase

Figure 8. Fusion Protein

Figure 9. Other

Figure 10. Recombinant Protein Drug R&D Revenue Market Share by Application in 2020

Figure 11. Diabetes Picture

Figure 12. Dwarfism Picture

Figure 13. Hemophilia Picture

Figure 14. Heart Disease Picture

Figure 15. Cancer Picture

Figure 16. Other Picture

Figure 17. Global Recombinant Protein Drug R&D Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 18. Global Recombinant Protein Drug R&D Revenue and Forecast (2016-2026) & (USD Million)

Figure 19. Global Recombinant Protein Drug R&D Revenue Market Share by Region (2016-2026)

Figure 20. Global Recombinant Protein Drug R&D Revenue Market Share by Region in 2020

Figure 21. North America Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Europe Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Asia-Pacific Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. South America Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 25. Middle East and Africa Recombinant Protein Drug R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 26. Recombinant Protein Drug R&D Market Drivers

Figure 27. Recombinant Protein Drug R&D Market Restraints

Figure 28. Recombinant Protein Drug R&D Market Trends

Figure 29. Eli Lilly Recent Developments and Future Plans

Figure 30. Novo Nordisk Recent Developments and Future Plans

Figure 31. Amgen Recent Developments and Future Plans

Figure 32. Merck Recent Developments and Future Plans

Figure 33. Sanofi Recent Developments and Future Plans

Figure 34. Pfizer Recent Developments and Future Plans

Figure 35. Roche Recent Developments and Future Plans

Figure 36. Gensci Recent Developments and Future Plans

Figure 37. Ankebio Recent Developments and Future Plans

Figure 38. United Cell Recent Developments and Future Plans

Figure 39. Sinobioway Hygene Recent Developments and Future Plans

Figure 40. Kexing Recent Developments and Future Plans

Figure 41. Dongbao Recent Developments and Future Plans

Figure 42. 3sbio Recent Developments and Future Plans

Figure 43. Gan&Lee Recent Developments and Future Plans

Figure 44. Hengrui Recent Developments and Future Plans

Figure 45. Global Recombinant Protein Drug R&D Revenue Share by Players in 2020

Figure 46. Recombinant Protein Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 47. Global Top 3 Players Recombinant Protein Drug R&D Revenue Market Share in 2020

Figure 48. Global Top 10 Players Recombinant Protein Drug R&D Revenue Market Share in 2020

Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 50. Global Recombinant Protein Drug R&D Revenue Share by Type in 2020

Figure 51. Global Recombinant Protein Drug R&D Market Share Forecast by Type (2021-2026)

Figure 52. Global Recombinant Protein Drug R&D Revenue Share by Application in 2020

Figure 53. Global Recombinant Protein Drug R&D Market Share Forecast by Application (2021-2026)

Figure 54. North America Recombinant Protein Drug R&D Sales Market Share by Type (2016-2026)

Figure 55. North America Recombinant Protein Drug R&D Sales Market Share by Application (2016-2026)

Figure 56. North America Recombinant Protein Drug R&D Revenue Market Share by Country (2016-2026)

Figure 57. United States Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Canada Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Mexico Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Europe Recombinant Protein Drug R&D Sales Market Share by Type (2016-2026)

Figure 61. Europe Recombinant Protein Drug R&D Sales Market Share by Application (2016-2026)

Figure 62. Europe Recombinant Protein Drug R&D Revenue Market Share by Country (2016-2026)

Figure 63. Germany Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. France Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. United Kingdom Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Russia Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Italy Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Asia-Pacific Recombinant Protein Drug R&D Sales Market Share by Type (2016-2026)

Figure 69. Asia-Pacific Recombinant Protein Drug R&D Sales Market Share by Application (2016-2026)

Figure 70. Asia-Pacific Recombinant Protein Drug R&D Revenue Market Share by Region (2016-2026)

Figure 71. China Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Japan Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South Korea Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. India Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Southeast Asia Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Australia Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South America Recombinant Protein Drug R&D Sales Market Share by Type (2016-2026)

Figure 78. South America Recombinant Protein Drug R&D Sales Market Share by Application (2016-2026)

Figure 79. South America Recombinant Protein Drug R&D Revenue Market Share by Country (2016-2026)

Figure 80. Brazil Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Argentina Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Middle East and Africa Recombinant Protein Drug R&D Sales Market Share by Type (2016-2026)

Figure 83. Middle East and Africa Recombinant Protein Drug R&D Sales Market Share by Application (2016-2026)

Figure 84. Middle East and Africa Recombinant Protein Drug R&D Revenue Market Share by Country (2016-2026)

Figure 85. Turkey Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Saudi Arabia Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. UAE Recombinant Protein Drug R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Methodology

Figure 89. Research Process and Data Source